or Try an Advanced Search...

    Tyrosine Kinase Stocks List

    Symbol Grade Name % Change
    ALLR F Allarity Therapeutics, Inc. 4.92
    AVBP F ArriVent BioPharma, Inc. -1.61
    BPMC A Blueprint Medicines Corporation -1.51
    BBIO F BridgeBio Pharma, Inc. 1.29
    COGT C Cogent Biosciences, Inc. -4.55
    EXEL F Exelixis, Inc. -1.79
    EYPT F EyePoint Pharmaceuticals, Inc. -4.58
    KALA F Kala Pharmaceuticals, Inc. 2.79
    KRON F Kronos Bio, Inc. -2.86
    NRIX C Nurix Therapeutics, Inc. -3.15
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Enzymes Biotechnology Receptor Tyrosine Kinase Treatment Of Cancer Eye Fibroblast Growth Factor Receptor Gastrointestinal Gastrointestinal Stromal Tumor Glucocorticoids Inflammation Macular Degeneration Mastocytosis Medicine Ophthalmic Organ Systems Small Molecule Therapies Solid Tumors

    Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase stocks.

    Symbol Grade Name Weight
    PBE C PowerShares Dynamic Biotech & Genome 7.34
    BBP D BioShares Biotechnology Products Fund 5.94
    IDNA C iShares Genomics Immunology and Healthcare ETF 5.65
    WDNA D WisdomTree BioRevolution Fund 4.37
    XBI D SPDR S&P Biotech ETF 4.15
    View all Tyrosine Kinase ETFs...
    Compare ETFs
    Compare BBP to XBI Compare IDNA to WDNA Compare IDNA to XBI

        Tyrosine Kinase Stocks Recent News

        Date Stock Title
        May 10 EYPT EyePoint Pharmaceuticals Q1 2024 Earnings: Revenue Surpasses Estimates Despite Challenges
        May 10 KRON Kronos Bio GAAP EPS of -$0.50 misses by $0.08, revenue of $2.52M
        May 9 KRON Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates
        May 9 KRON Kronos Bio Reports First-Quarter 2024 Financial Results
        May 8 EYPT EyePoint Pharmaceuticals GAAP EPS of -$0.55 misses by $0.17, revenue of $11.68M beats by $2.54M
        May 8 AVBP ArriVent BioPharma reports Q1 results
        May 8 AVBP ArriVent BioPharma Reports First Quarter 2024 Financial Results
        May 8 EYPT EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments
        May 8 EYPT Flywire Reports Q1 Loss, Joins ZoomInfo, Inspire Medical Systems And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
        May 7 EXEL Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
        May 7 EYPT EyePoint Stock: NPDR Endpoint Miss Is A Buying Opportunity Based On Lead Program
        May 7 COGT Cogent Biosciences EPS of -$0.62 misses by $0.11
        May 7 ALLR All You Need to Know About Allarity Therapeutics, Inc. (ALLR) Rating Upgrade to Buy
        May 7 ALLR Allarity Therapeutics Announces that All Series A Preferred and All Variable Priced Warrants have Converted to Common Stock
        May 7 COGT Cogent Biosciences Reports First Quarter 2024 Financial Results
        May 7 NRIX Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
        May 7 BPMC Zacks Industry Outlook Highlights BioMarin, Blueprint Medicines, Immunovant, Kymera and Ligand
        May 6 KRON Kronos Bio: Underestimated Drug Discovery Platform
        May 6 KRON Travere Therapeutics (TVTX) Reports Q1 Loss, Misses Revenue Estimates
        May 6 EYPT EyePoint's Setback In NPDR Does Not Bode Well For DME (Rating Downgrade)
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Protein Kinase Inhibitor Biopharmaceutical Enzymes Biotechnology Receptor Tyrosine Kinase Treatment Of Cancer Eye Fibroblast Growth Factor Receptor Gastrointestinal Gastrointestinal Stromal Tumor Glucocorticoids Inflammation Macular Degeneration Mastocytosis Medicine Ophthalmic Organ Systems Small Molecule Therapies Solid Tumors
        Tyrosine Kinase

        Tyrosine kinase is an enzyme that catalyzes the transfer of phosphate groups from ATP to tyrosine residues on proteins. It is involved in many cellular processes, including cell growth, differentiation, and migration. Tyrosine kinases are also involved in signal transduction pathways, which are important for cell communication and regulation. Mutations in tyrosine kinases can lead to cancer and other diseases.

        Browse All Tags